Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 45 entries
Sorted by: Best Match Show Resources per page
Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes.

The European respiratory journal

Reddel HK, Bacharier LB, Bateman ED, Brightling CE, Brusselle GG, Buhl R, Cruz AA, Duijts L, Drazen JM, FitzGerald JM, Fleming LJ, Inoue H, Ko FW, Krishnan JA, Levy ML, Lin J, Mortimer K, Pitrez PM, Sheikh A, Yorgancioglu AA, Boulet LP.
PMID: 34667060
Eur Respir J. 2021 Oct 19; doi: 10.1183/13993003.02730-2021. Epub 2021 Oct 19.

The Global Initiative for Asthma (GINA) Strategy Report provides clinicians with an annually updated evidence-based strategy for asthma management and prevention, which can be adapted for local circumstances (e.g., medication availability). This article summarizes key recommendations from GINA 2021,...

Cite
Reddel HK, Bacharier LB, Bateman ED, et al. Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes. Eur Respir J. 2021;doi: 10.1183/13993003.02730-2021.
Reddel, H. K., Bacharier, L. B., Bateman, E. D., Brightling, C. E., Brusselle, G. G., Buhl, R., Cruz, A. A., Duijts, L., Drazen, J. M., FitzGerald, J. M., Fleming, L. J., Inoue, H., Ko, F. W., Krishnan, J. A., Levy, M. L., Lin, J., Mortimer, K., Pitrez, P. M., Sheikh, A., Yorgancioglu, A. A., & Boulet, L. P. (2021). Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes. The European respiratory journal, . https://doi.org/10.1183/13993003.02730-2021
Reddel, Helen K, et al. "Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes." The European respiratory journal vol. (2021). doi: https://doi.org/10.1183/13993003.02730-2021
Reddel HK, Bacharier LB, Bateman ED, Brightling CE, Brusselle GG, Buhl R, Cruz AA, Duijts L, Drazen JM, FitzGerald JM, Fleming LJ, Inoue H, Ko FW, Krishnan JA, Levy ML, Lin J, Mortimer K, Pitrez PM, Sheikh A, Yorgancioglu AA, Boulet LP. Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes. Eur Respir J. 2021 Oct 19; doi: 10.1183/13993003.02730-2021. Epub 2021 Oct 19. PMID: 34667060.
Copy Download .nbib Format: NLM
Violence-related distress and lung function in two longitudinal studies of youth.

The European respiratory journal

Gaietto K, Han YY, Forno E, Bacharier LB, Phipatanakul W, Guilbert TW, Cabana MD, Ross K, Blatter J, Acosta-Pérez E, Miller GE, de la Hoz RE, Rosser FJ, Durrani S, Canino G, Wisniewski SR, Celedón JC.
PMID: 34588198
Eur Respir J. 2021 Sep 29; doi: 10.1183/13993003.02329-2021. Epub 2021 Sep 29.

Increasing violence-related distress over time was associated with worse lung function and worse asthma-related quality of life in youth with asthma despite treatment with low-dose inhaled corticosteroids.Exposure to violence has been associated with lower lung function in cross-sectional studies....

Cite
Gaietto K, Han YY, Forno E, et al. Violence-related distress and lung function in two longitudinal studies of youth. Eur Respir J. 2021;doi: 10.1183/13993003.02329-2021.
Gaietto, K., Han, Y. Y., Forno, E., Bacharier, L. B., Phipatanakul, W., Guilbert, T. W., Cabana, M. D., Ross, K., Blatter, J., Acosta-Pérez, E., Miller, G. E., de la Hoz, R. E., Rosser, F. J., Durrani, S., Canino, G., Wisniewski, S. R., & Celedón, J. C. (2021). Violence-related distress and lung function in two longitudinal studies of youth. The European respiratory journal, . https://doi.org/10.1183/13993003.02329-2021
Gaietto, Kristina, et al. "Violence-related distress and lung function in two longitudinal studies of youth." The European respiratory journal vol. (2021). doi: https://doi.org/10.1183/13993003.02329-2021
Gaietto K, Han YY, Forno E, Bacharier LB, Phipatanakul W, Guilbert TW, Cabana MD, Ross K, Blatter J, Acosta-Pérez E, Miller GE, de la Hoz RE, Rosser FJ, Durrani S, Canino G, Wisniewski SR, Celedón JC. Violence-related distress and lung function in two longitudinal studies of youth. Eur Respir J. 2021 Sep 29; doi: 10.1183/13993003.02329-2021. Epub 2021 Sep 29. PMID: 34588198.
Copy Download .nbib Format: NLM
A distributed geospatial approach to describe community characteristics for multisite studies.

Journal of clinical and translational science

Ryan PH, Brokamp C, Blossom J, Lothrop N, Miller RL, Beamer PI, Visness CM, Zanobetti A, Andrews H, Bacharier LB, Hartert T, Johnson CC, Ownby D, Lemanske RF, Gibson H, Requia W, Coull B, Zoratti EM, Wright AL, Martinez FD, Seroogy CM, Gern JE, Gold DR.
PMID: 34007469
J Clin Transl Sci. 2021 Feb 05;5(1):e86. doi: 10.1017/cts.2021.7.

Understanding place-based contributors to health requires geographically and culturally diverse study populations, but sharing location data is a significant challenge to multisite studies. Here, we describe a standardized and reproducible method to perform geospatial analyses for multisite studies. Using...

Cite
Ryan PH, Brokamp C, Blossom J, et al. A distributed geospatial approach to describe community characteristics for multisite studies. J Clin Transl Sci. 2021;5(1):e86doi: 10.1017/cts.2021.7.
Ryan, P. H., Brokamp, C., Blossom, J., Lothrop, N., Miller, R. L., Beamer, P. I., Visness, C. M., Zanobetti, A., Andrews, H., Bacharier, L. B., Hartert, T., Johnson, C. C., Ownby, D., Lemanske, R. F., Gibson, H., Requia, W., Coull, B., Zoratti, E. M., Wright, A. L., Martinez, F. D., Seroogy, C. M., Gern, J. E., & Gold, D. R. (2021). A distributed geospatial approach to describe community characteristics for multisite studies. Journal of clinical and translational science, 5(1), e86. https://doi.org/10.1017/cts.2021.7
Ryan, Patrick H, et al. "A distributed geospatial approach to describe community characteristics for multisite studies." Journal of clinical and translational science vol. 5,1 (2021): e86. doi: https://doi.org/10.1017/cts.2021.7
Ryan PH, Brokamp C, Blossom J, Lothrop N, Miller RL, Beamer PI, Visness CM, Zanobetti A, Andrews H, Bacharier LB, Hartert T, Johnson CC, Ownby D, Lemanske RF, Gibson H, Requia W, Coull B, Zoratti EM, Wright AL, Martinez FD, Seroogy CM, Gern JE, Gold DR. A distributed geospatial approach to describe community characteristics for multisite studies. J Clin Transl Sci. 2021 Feb 05;5(1):e86. doi: 10.1017/cts.2021.7. PMID: 34007469; PMCID: PMC8111696.
Copy Download .nbib Format: NLM
Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes.

Respirology (Carlton, Vic.)

Reddel HK, Bacharier LB, Bateman ED, Brightling CE, Brusselle GG, Buhl R, Cruz AA, Duijts L, Drazen JM, FitzGerald JM, Fleming LJ, Inoue H, Ko FW, Krishnan JA, Levy ML, Lin J, Mortimer K, Pitrez PM, Sheikh A, Yorgancioglu AA, Boulet LP.
PMID: 34668278
Respirology. 2021 Oct 19; doi: 10.1111/resp.14174. Epub 2021 Oct 19.

The Global Initiative for Asthma (GINA) Strategy Report provides clinicians with an annually updated evidence-based strategy for asthma management and prevention, which can be adapted for local circumstances (e.g., medication availability). This article summarizes key recommendations from GINA 2021,...

Cite
Reddel HK, Bacharier LB, Bateman ED, et al. Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes. Respirology. 2021;doi: 10.1111/resp.14174.
Reddel, H. K., Bacharier, L. B., Bateman, E. D., Brightling, C. E., Brusselle, G. G., Buhl, R., Cruz, A. A., Duijts, L., Drazen, J. M., FitzGerald, J. M., Fleming, L. J., Inoue, H., Ko, F. W., Krishnan, J. A., Levy, M. L., Lin, J., Mortimer, K., Pitrez, P. M., Sheikh, A., Yorgancioglu, A. A., & Boulet, L. P. (2021). Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes. Respirology (Carlton, Vic.), . https://doi.org/10.1111/resp.14174
Reddel, Helen K, et al. "Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes." Respirology (Carlton, Vic.) vol. (2021). doi: https://doi.org/10.1111/resp.14174
Reddel HK, Bacharier LB, Bateman ED, Brightling CE, Brusselle GG, Buhl R, Cruz AA, Duijts L, Drazen JM, FitzGerald JM, Fleming LJ, Inoue H, Ko FW, Krishnan JA, Levy ML, Lin J, Mortimer K, Pitrez PM, Sheikh A, Yorgancioglu AA, Boulet LP. Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes. Respirology. 2021 Oct 19; doi: 10.1111/resp.14174. Epub 2021 Oct 19. PMID: 34668278.
Copy Download .nbib Format: NLM
Inducible expression quantitative trait locus analysis of the MUC5AC gene in asthma in urban populations of children.

The Journal of allergy and clinical immunology

Altman MC, Flynn K, Rosasco MG, Dapas M, Kattan M, Lovinsky-Desir S, O'Connor GT, Gill MA, Gruchalla RS, Liu AH, Pongracic JA, Khurana Hershey GK, Zoratti EM, Teach SJ, Rastrogi D, Wood RA, Bacharier LB, LeBeau P, Gergen PJ, Togias A, Busse WW, Presnell S, Gern JE, Ober C, Jackson DJ.
PMID: 34019912
J Allergy Clin Immunol. 2021 Dec;148(6):1505-1514. doi: 10.1016/j.jaci.2021.04.035. Epub 2021 May 18.

BACKGROUND: Mucus plugging can worsen asthma control, lead to reduced lung function and fatal exacerbations. MUC5AC is the secretory mucin implicated in mucus plugging, and MUC5AC gene expression has been associated with development of airway obstruction and asthma exacerbations...

Cite
Altman MC, Flynn K, Rosasco MG, et al. Inducible expression quantitative trait locus analysis of the MUC5AC gene in asthma in urban populations of children. J Allergy Clin Immunol. 2021;148(6):1505-1514doi: 10.1016/j.jaci.2021.04.035.
Altman, M. C., Flynn, K., Rosasco, M. G., Dapas, M., Kattan, M., Lovinsky-Desir, S., O'Connor, G. T., Gill, M. A., Gruchalla, R. S., Liu, A. H., Pongracic, J. A., Khurana Hershey, G. K., Zoratti, E. M., Teach, S. J., Rastrogi, D., Wood, R. A., Bacharier, L. B., LeBeau, P., Gergen, P. J., Togias, A., Busse, W. W., Presnell, S., Gern, J. E., Ober, C., Jackson, D. J. (2021). Inducible expression quantitative trait locus analysis of the MUC5AC gene in asthma in urban populations of children. The Journal of allergy and clinical immunology, 148(6), 1505-1514. https://doi.org/10.1016/j.jaci.2021.04.035
Altman, Matthew C, et al. "Inducible expression quantitative trait locus analysis of the MUC5AC gene in asthma in urban populations of children." The Journal of allergy and clinical immunology vol. 148,6 (2021): 1505-1514. doi: https://doi.org/10.1016/j.jaci.2021.04.035
Altman MC, Flynn K, Rosasco MG, Dapas M, Kattan M, Lovinsky-Desir S, O'Connor GT, Gill MA, Gruchalla RS, Liu AH, Pongracic JA, Khurana Hershey GK, Zoratti EM, Teach SJ, Rastrogi D, Wood RA, Bacharier LB, LeBeau P, Gergen PJ, Togias A, Busse WW, Presnell S, Gern JE, Ober C, Jackson DJ. Inducible expression quantitative trait locus analysis of the MUC5AC gene in asthma in urban populations of children. J Allergy Clin Immunol. 2021 Dec;148(6):1505-1514. doi: 10.1016/j.jaci.2021.04.035. Epub 2021 May 18. PMID: 34019912; PMCID: PMC8599524.
Copy Download .nbib Format: NLM
Long-Term Respiratory Consequences of Early-Life Respiratory Viral Infections: A Pragmatic Approach to Fundamental Questions.

The journal of allergy and clinical immunology. In practice

Achten NB, van Rossum AMC, Bacharier LB, Fitzpatrick AM, Hartert TV.
PMID: 34942383
J Allergy Clin Immunol Pract. 2021 Dec 20; doi: 10.1016/j.jaip.2021.12.005. Epub 2021 Dec 20.

Early-life viral infection can have profound effects on the developing lung and immune systems, both important in asthma development. For decades, research has aimed to establish whether there is a causal link between these viral infections as an exposure...

Cite
Achten NB, van Rossum AMC, Bacharier LB, et al. Long-Term Respiratory Consequences of Early-Life Respiratory Viral Infections: A Pragmatic Approach to Fundamental Questions. J Allergy Clin Immunol Pract. 2021;doi: 10.1016/j.jaip.2021.12.005.
Achten, N. B., van Rossum, A. M. C., Bacharier, L. B., Fitzpatrick, A. M., & Hartert, T. V. (2021). Long-Term Respiratory Consequences of Early-Life Respiratory Viral Infections: A Pragmatic Approach to Fundamental Questions. The journal of allergy and clinical immunology. In practice, . https://doi.org/10.1016/j.jaip.2021.12.005
Achten, Niek B, et al. "Long-Term Respiratory Consequences of Early-Life Respiratory Viral Infections: A Pragmatic Approach to Fundamental Questions." The journal of allergy and clinical immunology. In practice vol. (2021). doi: https://doi.org/10.1016/j.jaip.2021.12.005
Achten NB, van Rossum AMC, Bacharier LB, Fitzpatrick AM, Hartert TV. Long-Term Respiratory Consequences of Early-Life Respiratory Viral Infections: A Pragmatic Approach to Fundamental Questions. J Allergy Clin Immunol Pract. 2021 Dec 20; doi: 10.1016/j.jaip.2021.12.005. Epub 2021 Dec 20. PMID: 34942383.
Copy Download .nbib Format: NLM
Pharmacogenetic studies of long-acting beta agonist and inhaled corticosteroid responsiveness in randomised controlled trials of individuals of African descent with asthma.

The Lancet. Child & adolescent health

Ortega VE, Daya M, Szefler SJ, Bleecker ER, Chinchilli VM, Phipatanakul W, Mauger D, Martinez FD, Herrera-Luis E, Pino-Yanes M, Hawkins GA, Ampleford EJ, Kunselman SJ, Cox C, Bacharier LB, Cabana MD, Cardet JC, Castro M, Denlinger LC, Eng C, Fitzpatrick AM, Holguin F, Hu D, Jackson DJ, Jarjour N, Kraft M, Krishnan JA, Lazarus SC, Lemanske RF, Lima JJ, Lugogo N, Mak A, Moore WC, Naureckas ET, Peters SP, Pongracic JA, Sajuthi SP, Seibold MA, Smith LJ, Solway J, Sorkness CA, Wenzel S, White SR, Burchard EG, Barnes K, Meyers DA, Israel E, Wechsler ME.
PMID: 34762840
Lancet Child Adolesc Health. 2021 Dec;5(12):862-872. doi: 10.1016/S2352-4642(21)00268-6. Epub 2021 Nov 09.

BACKGROUND: Pharmacogenetic studies in asthma cohorts, primarily made up of White people of European descent, have identified loci associated with response to inhaled beta agonists and corticosteroids (ICSs). Differences exist in how individuals from different ancestral backgrounds respond to...

Cite
Ortega VE, Daya M, Szefler SJ, et al. Pharmacogenetic studies of long-acting beta agonist and inhaled corticosteroid responsiveness in randomised controlled trials of individuals of African descent with asthma. Lancet Child Adolesc Health. 2021;5(12):862-872doi: 10.1016/S2352-4642(21)00268-6.
Ortega, V. E., Daya, M., Szefler, S. J., Bleecker, E. R., Chinchilli, V. M., Phipatanakul, W., Mauger, D., Martinez, F. D., Herrera-Luis, E., Pino-Yanes, M., Hawkins, G. A., Ampleford, E. J., Kunselman, S. J., Cox, C., Bacharier, L. B., Cabana, M. D., Cardet, J. C., Castro, M., Denlinger, L. C., Eng, C., Fitzpatrick, A. M., Holguin, F., Hu, D., Jackson, D. J., Jarjour, N., Kraft, M., Krishnan, J. A., Lazarus, S. C., Lemanske, R. F., Lima, J. J., Lugogo, N., Mak, A., Moore, W. C., Naureckas, E. T., Peters, S. P., Pongracic, J. A., Sajuthi, S. P., Seibold, M. A., Smith, L. J., Solway, J., Sorkness, C. A., Wenzel, S., White, S. R., Burchard, E. G., Barnes, K., Meyers, D. A., Israel, E., Wechsler, M. E. (2021). Pharmacogenetic studies of long-acting beta agonist and inhaled corticosteroid responsiveness in randomised controlled trials of individuals of African descent with asthma. The Lancet. Child & adolescent health, 5(12), 862-872. https://doi.org/10.1016/S2352-4642(21)00268-6
Ortega, Victor E, et al. "Pharmacogenetic studies of long-acting beta agonist and inhaled corticosteroid responsiveness in randomised controlled trials of individuals of African descent with asthma." The Lancet. Child & adolescent health vol. 5,12 (2021): 862-872. doi: https://doi.org/10.1016/S2352-4642(21)00268-6
Ortega VE, Daya M, Szefler SJ, Bleecker ER, Chinchilli VM, Phipatanakul W, Mauger D, Martinez FD, Herrera-Luis E, Pino-Yanes M, Hawkins GA, Ampleford EJ, Kunselman SJ, Cox C, Bacharier LB, Cabana MD, Cardet JC, Castro M, Denlinger LC, Eng C, Fitzpatrick AM, Holguin F, Hu D, Jackson DJ, Jarjour N, Kraft M, Krishnan JA, Lazarus SC, Lemanske RF, Lima JJ, Lugogo N, Mak A, Moore WC, Naureckas ET, Peters SP, Pongracic JA, Sajuthi SP, Seibold MA, Smith LJ, Solway J, Sorkness CA, Wenzel S, White SR, Burchard EG, Barnes K, Meyers DA, Israel E, Wechsler ME. Pharmacogenetic studies of long-acting beta agonist and inhaled corticosteroid responsiveness in randomised controlled trials of individuals of African descent with asthma. Lancet Child Adolesc Health. 2021 Dec;5(12):862-872. doi: 10.1016/S2352-4642(21)00268-6. Epub 2021 Nov 09. PMID: 34762840.
Copy Download .nbib Format: NLM
The Precision Interventions for Severe and/or Exacerbation-Prone (PrecISE) Asthma Network: An overview of Network organization, procedures, and interventions.

The Journal of allergy and clinical immunology

Georas SN, Wright RJ, Ivanova A, Israel E, LaVange LM, Akuthota P, Carr TF, Denlinger LC, Fajt ML, Kumar R, O'Neal WK, Phipatanakul W, Szefler SJ, Aronica MA, Bacharier LB, Burbank AJ, Castro M, Crotty Alexander L, Bamdad J, Cardet JC, Comhair SAA, Covar RA, DiMango EA, Erwin K, Erzurum SC, Fahy JV, Gaffin JM, Gaston B, Gerald LB, Hoffman EA, Holguin F, Jackson DJ, James J, Jarjour NN, Kenyon NJ, Khatri S, Kirwan JP, Kraft M, Krishnan JA, Liu AH, Liu MC, Marquis MA, Martinez F, Mey J, Moore WC, Moy JN, Ortega VE, Peden DB, Pennington E, Peters MC, Ross K, Sanchez M, Smith LJ, Sorkness RL, Wechsler ME, Wenzel SE, White SR, Zein J, Zeki AA, Noel P.
PMID: 34848210
J Allergy Clin Immunol. 2021 Nov 29; doi: 10.1016/j.jaci.2021.10.035. Epub 2021 Nov 29.

Asthma is a heterogeneous disease, with multiple underlying inflammatory pathways and structural airway abnormalities that impact disease persistence and severity. Recent progress has been made in developing targeted asthma therapeutics, especially for subjects with eosinophilic asthma. However, there is...

Cite
Georas SN, Wright RJ, Ivanova A, et al. The Precision Interventions for Severe and/or Exacerbation-Prone (PrecISE) Asthma Network: An overview of Network organization, procedures, and interventions. J Allergy Clin Immunol. 2021;doi: 10.1016/j.jaci.2021.10.035.
Georas, S. N., Wright, R. J., Ivanova, A., Israel, E., LaVange, L. M., Akuthota, P., Carr, T. F., Denlinger, L. C., Fajt, M. L., Kumar, R., O'Neal, W. K., Phipatanakul, W., Szefler, S. J., Aronica, M. A., Bacharier, L. B., Burbank, A. J., Castro, M., Crotty Alexander, L., Bamdad, J., Cardet, J. C., Comhair, S. A. A., Covar, R. A., DiMango, E. A., Erwin, K., Erzurum, S. C., Fahy, J. V., Gaffin, J. M., Gaston, B., Gerald, L. B., Hoffman, E. A., Holguin, F., Jackson, D. J., James, J., Jarjour, N. N., Kenyon, N. J., Khatri, S., Kirwan, J. P., Kraft, M., Krishnan, J. A., Liu, A. H., Liu, M. C., Marquis, M. A., Martinez, F., Mey, J., Moore, W. C., Moy, J. N., Ortega, V. E., Peden, D. B., Pennington, E., Peters, M. C., Ross, K., Sanchez, M., Smith, L. J., Sorkness, R. L., Wechsler, M. E., Wenzel, S. E., White, S. R., Zein, J., Zeki, A. A., Noel, P. (2021). The Precision Interventions for Severe and/or Exacerbation-Prone (PrecISE) Asthma Network: An overview of Network organization, procedures, and interventions. The Journal of allergy and clinical immunology, . https://doi.org/10.1016/j.jaci.2021.10.035
Georas, Steve N, et al. "The Precision Interventions for Severe and/or Exacerbation-Prone (PrecISE) Asthma Network: An overview of Network organization, procedures, and interventions." The Journal of allergy and clinical immunology vol. (2021). doi: https://doi.org/10.1016/j.jaci.2021.10.035
Georas SN, Wright RJ, Ivanova A, Israel E, LaVange LM, Akuthota P, Carr TF, Denlinger LC, Fajt ML, Kumar R, O'Neal WK, Phipatanakul W, Szefler SJ, Aronica MA, Bacharier LB, Burbank AJ, Castro M, Crotty Alexander L, Bamdad J, Cardet JC, Comhair SAA, Covar RA, DiMango EA, Erwin K, Erzurum SC, Fahy JV, Gaffin JM, Gaston B, Gerald LB, Hoffman EA, Holguin F, Jackson DJ, James J, Jarjour NN, Kenyon NJ, Khatri S, Kirwan JP, Kraft M, Krishnan JA, Liu AH, Liu MC, Marquis MA, Martinez F, Mey J, Moore WC, Moy JN, Ortega VE, Peden DB, Pennington E, Peters MC, Ross K, Sanchez M, Smith LJ, Sorkness RL, Wechsler ME, Wenzel SE, White SR, Zein J, Zeki AA, Noel P. The Precision Interventions for Severe and/or Exacerbation-Prone (PrecISE) Asthma Network: An overview of Network organization, procedures, and interventions. J Allergy Clin Immunol. 2021 Nov 29; doi: 10.1016/j.jaci.2021.10.035. Epub 2021 Nov 29. PMID: 34848210.
Copy Download .nbib Format: NLM
Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes.

The journal of allergy and clinical immunology. In practice

Reddel HK, Bacharier LB, Bateman ED, Brightling CE, Brusselle GG, Buhl R, Cruz AA, Duijts L, Drazen JM, FitzGerald JM, Fleming LJ, Inoue H, Ko FW, Krishnan JA, Levy ML, Lin J, Mortimer K, Pitrez PM, Sheikh A, Yorgancioglu AA, Boulet LP.
PMID: 34718211
J Allergy Clin Immunol Pract. 2021 Oct 27; doi: 10.1016/j.jaip.2021.10.001. Epub 2021 Oct 27.

The Global Initiative for Asthma (GINA) Strategy Report provides clinicians with an annually updated evidence-based strategy for asthma management and prevention, which can be adapted for local circumstances (e.g., medication availability). This article summarizes key recommendations from GINA 2021,...

Cite
Reddel HK, Bacharier LB, Bateman ED, et al. Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes. J Allergy Clin Immunol Pract. 2021;doi: 10.1016/j.jaip.2021.10.001.
Reddel, H. K., Bacharier, L. B., Bateman, E. D., Brightling, C. E., Brusselle, G. G., Buhl, R., Cruz, A. A., Duijts, L., Drazen, J. M., FitzGerald, J. M., Fleming, L. J., Inoue, H., Ko, F. W., Krishnan, J. A., Levy, M. L., Lin, J., Mortimer, K., Pitrez, P. M., Sheikh, A., Yorgancioglu, A. A., & Boulet, L. P. (2021). Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes. The journal of allergy and clinical immunology. In practice, . https://doi.org/10.1016/j.jaip.2021.10.001
Reddel, Helen K, et al. "Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes." The journal of allergy and clinical immunology. In practice vol. (2021). doi: https://doi.org/10.1016/j.jaip.2021.10.001
Reddel HK, Bacharier LB, Bateman ED, Brightling CE, Brusselle GG, Buhl R, Cruz AA, Duijts L, Drazen JM, FitzGerald JM, Fleming LJ, Inoue H, Ko FW, Krishnan JA, Levy ML, Lin J, Mortimer K, Pitrez PM, Sheikh A, Yorgancioglu AA, Boulet LP. Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes. J Allergy Clin Immunol Pract. 2021 Oct 27; doi: 10.1016/j.jaip.2021.10.001. Epub 2021 Oct 27. PMID: 34718211.
Copy Download .nbib Format: NLM
Prospective Observational Study of Clinical Outcomes After Intravenous Magnesium for Moderate and Severe Acute Asthma Exacerbations in Children.

The journal of allergy and clinical immunology. In practice

Arnold DH, Gong W, Antoon JW, Bacharier LB, Stewart TG, Johnson DP, Akers WS, Hartert TV.
PMID: 34915226
J Allergy Clin Immunol Pract. 2021 Dec 13; doi: 10.1016/j.jaip.2021.11.028. Epub 2021 Dec 13.

BACKGROUND: There is limited knowledge regarding whether intravenous magnesium (IV-Mg) improves outcomes in children with acute asthma exacerbations.OBJECTIVE: To examine whether IV-Mg improves outcomes in children with moderate and severe exacerbations.METHODS: We performed a secondary analysis using data from...

Cite
Arnold DH, Gong W, Antoon JW, et al. Prospective Observational Study of Clinical Outcomes After Intravenous Magnesium for Moderate and Severe Acute Asthma Exacerbations in Children. J Allergy Clin Immunol Pract. 2021;doi: 10.1016/j.jaip.2021.11.028.
Arnold, D. H., Gong, W., Antoon, J. W., Bacharier, L. B., Stewart, T. G., Johnson, D. P., Akers, W. S., & Hartert, T. V. (2021). Prospective Observational Study of Clinical Outcomes After Intravenous Magnesium for Moderate and Severe Acute Asthma Exacerbations in Children. The journal of allergy and clinical immunology. In practice, . https://doi.org/10.1016/j.jaip.2021.11.028
Arnold, Donald H, et al. "Prospective Observational Study of Clinical Outcomes After Intravenous Magnesium for Moderate and Severe Acute Asthma Exacerbations in Children." The journal of allergy and clinical immunology. In practice vol. (2021). doi: https://doi.org/10.1016/j.jaip.2021.11.028
Arnold DH, Gong W, Antoon JW, Bacharier LB, Stewart TG, Johnson DP, Akers WS, Hartert TV. Prospective Observational Study of Clinical Outcomes After Intravenous Magnesium for Moderate and Severe Acute Asthma Exacerbations in Children. J Allergy Clin Immunol Pract. 2021 Dec 13; doi: 10.1016/j.jaip.2021.11.028. Epub 2021 Dec 13. PMID: 34915226.
Copy Download .nbib Format: NLM
17q12-q21 variants interact with early-life exposures to modify asthma risk in Black children.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Gereige JD, Morin A, Calatroni A, Visness CM, Wood RA, Kattan M, Bacharier LB, Becker P, Altman MC, Gern JE, Ober C, O'Connor GT.
PMID: 34862819
Clin Exp Allergy. 2021 Dec 04; doi: 10.1111/cea.14074. Epub 2021 Dec 04.

Genetic factors and early-life exposures

Cite
Gereige JD, Morin A, Calatroni A, et al. 17q12-q21 variants interact with early-life exposures to modify asthma risk in Black children. Clin Exp Allergy. 2021;doi: 10.1111/cea.14074.
Gereige, J. D., Morin, A., Calatroni, A., Visness, C. M., Wood, R. A., Kattan, M., Bacharier, L. B., Becker, P., Altman, M. C., Gern, J. E., Ober, C., & O'Connor, G. T. (2021). 17q12-q21 variants interact with early-life exposures to modify asthma risk in Black children. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, . https://doi.org/10.1111/cea.14074
Gereige, Jessica D, et al. "17q12-q21 variants interact with early-life exposures to modify asthma risk in Black children." Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology vol. (2021). doi: https://doi.org/10.1111/cea.14074
Gereige JD, Morin A, Calatroni A, Visness CM, Wood RA, Kattan M, Bacharier LB, Becker P, Altman MC, Gern JE, Ober C, O'Connor GT. 17q12-q21 variants interact with early-life exposures to modify asthma risk in Black children. Clin Exp Allergy. 2021 Dec 04; doi: 10.1111/cea.14074. Epub 2021 Dec 04. PMID: 34862819.
Copy Download .nbib Format: NLM
17q12-q21 variants interact with early-life exposures to modify asthma risk in Black children.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Gereige JD, Morin A, Calatroni A, Visness CM, Wood RA, Kattan M, Bacharier LB, Becker P, Altman MC, Gern JE, Ober C, O'Connor GT.
PMID: 34862819
Clin Exp Allergy. 2021 Dec 04; doi: 10.1111/cea.14074. Epub 2021 Dec 04.

No abstract available.

Cite
Gereige JD, Morin A, Calatroni A, et al. 17q12-q21 variants interact with early-life exposures to modify asthma risk in Black children. Clin Exp Allergy. 2021;doi: 10.1111/cea.14074.
Gereige, J. D., Morin, A., Calatroni, A., Visness, C. M., Wood, R. A., Kattan, M., Bacharier, L. B., Becker, P., Altman, M. C., Gern, J. E., Ober, C., & O'Connor, G. T. (2021). 17q12-q21 variants interact with early-life exposures to modify asthma risk in Black children. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, . https://doi.org/10.1111/cea.14074
Gereige, Jessica D, et al. "17q12-q21 variants interact with early-life exposures to modify asthma risk in Black children." Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology vol. (2021). doi: https://doi.org/10.1111/cea.14074
Gereige JD, Morin A, Calatroni A, Visness CM, Wood RA, Kattan M, Bacharier LB, Becker P, Altman MC, Gern JE, Ober C, O'Connor GT. 17q12-q21 variants interact with early-life exposures to modify asthma risk in Black children. Clin Exp Allergy. 2021 Dec 04; doi: 10.1111/cea.14074. Epub 2021 Dec 04. PMID: 34862819.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 45 entries